Introduction
In classical Hodgkin lymphoma (cHL), the rare Hodgkin and Reed/Sternberg (HRS) tumour cells are derived from mature B cells, presumably pre-apoptotic germinal center (GC) B cells that had acquired unfavorable immunoglobulin V gene mutations. 1, 2 However, HRS cells phenotypically do not resemble B cells anymore. They lack expression of most B-lymphocyte markers, including the B-cell receptor (BCR) and important B-cell transcription factors. [3] [4] [5] This loss of the B cell gene expression program represents a phenomenon hereafter termed dedifferentiation. Additionally, HRS cells express multiple genes that are not normally expressed by B cells. The aberrantly expressed genes include NOTCH1, a T cell transcription factor that regulates the differentiation of lymphoid precursors into T but not B cells, and ID2, which is expressed by natural killer cells and suppresses B cell genes. [6] [7] [8] Hence, HRS cells have undergone a dramatic reprogramming in comparison to the B cells they stem from. 6, 7, 9 The loss of the B cell gene expression program may be a strategy of the HRS (precursor) cells to escape the selectional forces on GC B cells to express a highaffinity BCR or otherwise undergo apoptosis. 5 Indeed, partial reexpression of the B cell program in cHL cell lines impaired their survival. 10 Expression and activity of ID2, NOTCH1, AP-1, NFκB and JAK/STAT signalling, which are all hallmarks of HRS cells, 2, 11, 12 are induced upon hypoxia in various cell types. [13] [14] [15] [16] Moreover, a general dedifferentiation is typically seen in hypoxic cancer cells, and ID2 and NOTCH1 contribute to this phenomenon. 14, 17, 18 Thus, there are key features of the HRS cell phenotype that resemble hypoxic cells.
The main regulator of the hypoxic response is the transcription factor hypoxiainducible factor (HIF)-1. HIF-1 is composed of an oxygen-regulated α-subunit and a constitutively expressed β -subunit. Under well-oxygenated conditions, HIF-1α or its homologue HIF-2α are constitutively produced but posttranslationally hydroxylated by prolyl hydroxylases. Hydroxy-proline HIF-α is polyubiquitinated and degraded. Decreased hydroxylase activity under hypoxic conditions allows the accumulation of HIF-1/2α and after dimerization with HIF-1β HIF-1 acts as a master regulator of the hypoxic response. 19 HIF-1α is expressed in some GC B cells and moderately in many B cell non-Hodgkin lymphomas (B-NHL). 20 The pronounced angiogenic activity observed in cHL lymph nodes 21, 22 is presumably due to hypoxic conditions. However 
Hypoxia induces a partial downregulation of B cell markers
For the analysis of a potential downregulation of typical B cell genes in PB B cells and GCB-DLBCL cell lines upon hypoxia, we selected CD19, CD79b, PAX5, EBF1, BOB1, and LCK, as these are also downregulated in HRS cells in comparison to normal GC B cells. 5, 23, [26] [27] [28] The results of the qRT-PCR analysis for these markers after incubation of the cells for 24 h under normoxia or hypoxia were heterogeneous. CD79b transcription showed a moderate downregulation under hypoxic conditions in SUDHL4 cells, and LCK was 3.2-fold downregulated in PB B cells. SUDHL6 downregulated CD19 at early time points of 6 h and 6 14 h, and PAX5 at 6 h ( Fig. 2A, B) . However, most genes did not show a significant and consistent regulation under hypoxic conditions for the PB B cells and DLBCL lines. EBF1 and BOB1 even showed a 2-fold and 4-fold upregulation in normal B cells, respectively, and a 2-fold upregulation in SUDHL6 cells (Fig. 2B) .
For CD19 and CD79b we also studied their regulation at the protein level by flow cytometry. Hypoxic SUDHL4 and SUDHL6 cells displayed a significantly reduced expression of CD19 and CD79b after 24 h (Fig. 2C, D) . As tested only for SUDHL6, that effect was even more significant upon prolonged hypoxia for 48 h (Fig. 2D) . PB B cells did not downregulate CD19 or CD79b.
Taken together, exposure to hypoxia did not result in a consistent downregulation of all B cell genes tested. Nevertheless, a clear downregulation of CD19 and CD79b in the GCB-DLBCL cell lines and of LCK in the PB B cells was observed.
Key factors of HRS cell dedifferentiation and survival are HIF-1 inducible
Hypoxia-induced expression of ID2 and NOTCH1 in B cells was tested because of their aberrant expression in HRS cells and their role in maintaining "the lost B cell identity" of HRS cells. [7] [8] [9] We also studied the NOTCH1 target genes HES, HEY1, and DTX1. DTX1 and HEY1
are NOTCH1 target genes known to be highly expressed in HRS cells. 9,29 ID2 mRNA was significantly upregulated in B cells and both DLBCL cell lines upon 24 h of hypoxia (Fig. 3A) .
In SUDHL6, ID2 was expressed at 3-fold increased level already after 6 h ( Fig. 3D ).
NOTCH1 mRNA levels were not significantly modulated upon hypoxia (Fig. 3A) . However, the NOTCH1 target genes DTX1, HES1 and HEY1 were 4.8 -8.1 times higher expressed in hypoxic B cells, likely reflecting an active NOTCH1 pathway under hypoxic conditions. The DLBCL lines displayed the same tendency, but the effect was moderate.
In HRS cells, ID2 expression is partly caused by the AP-1 transcription factor JUN. 7 The aberrantly expressed JUN stimulates proliferation and contributes to the differentiation status of HRS cells. 11 JUN expression is inducible by low oxygen conditions. 30 We detected higher protein levels of JUN in hypoxic PB B cells, and hypoxia further increased JUN protein levels in the HRS cell line L1236 (Fig. 3B) . B-NHL derived cell lines BL41 and SUDHL6 remained JUN-negative under hypoxic conditions.
The NFκB pathway is constitutively active in HRS cells, and NFκB function is essential for survival of HRS cells. 2, 12 NFκB activity is inducible by hypoxia in various cell types. 13, 16 Under hypoxic conditions, PB B cells showed a significant upregulation of the three NFκB targets IL6 (24.7-fold), IRF4 (7.9-fold) and BCL2 (7.8-fold) (Fig. 3C ). In DLBCL lines this effect was weaker or not visible, but SUDHL4 showed a 6-fold induction of IRF4.
As HRS cells are very large and granular cells, we analysed whether hypoxic conditions induced an increase in cell size and/or granularity by measuring forward and side scatter, respectively, in the flow cytometric analyses. No increase in forward scatter was observed, but hypoxic SUDHL4 cells showed a significant higher side scatter (Supplementary Figure 1A) .
Taken together, hypoxic B cells and GCB-DLBCL lines upregulated ID2, and normal
B cell upregulated JUN and showed increased activity of NOTCH1 and NFκB, all of which are key factors of HRS cell pathophysiology.
Hypoxia-induced deregulation of growth factors
We tested MYC expression due to its role as an oncogene and driver of proliferation in many lymphomas, 31 and its known expression in HRS cells. 23,32 MYC was over 6-fold upregulated in hypoxic primary B cells (Fig. 4A) . No upregulation was observed for the NHL cell lines, perhaps because DLBCL cells already express considerable levels of MYC. 33 The dual specificity phosphatase 1 (DUSP1) is involved in regulating extracellular signal-regulated kinase (ERK) and AP-1. 34, 35 Additionally, DUSP1 has been functionally linked to HIF-1α, 36, 37 and is induced by hypoxia in solid tumors. 38 As DUSP1 transcript levels are upregulated in primary HRS cells in comparison to normal GC B cells, 23 we tested whether DUSP1 is also hypoxia-inducible in B cells. Indeed, in hypoxic B cells DUSP1 was expressed 8.6-fold higher than in control cells (Fig. 4A) . Even though the expression levels of DUSP1 of the HL cell lines were not much higher or even slightly lower than those of GC B cells (ref. 23 and data not shown) we tested the role of DUSP1 in HL cell lines. Incubating various cell lines with an inhibitor mainly targeting DUSP1 (and with lower efficiency DUSP6), hereafter called DUSP1/6i, revealed a strong attenuation of cell activity specifically for the HL cell lines (Fig. 4B ). Burkitt lymphoma cell lines were affected by DUSP1 inhibition only at high concentrations of the inhibitor, and two other cell lines were resistant even at high concentrations (Fig. 4B ).
Taken together, transcription of the growth and proliferation factor MYC is induced in normal B cells under hypoxia, and HL cell lines show a strong survival dependency on DUSP1, which is inducible in B cells under hypoxia.
Modulation of epigenetic factors in B lineage cells under hypoxia
As epigenetic factors may stabilize changes in gene expression induced by hypoxia, we investigated the epigenetic regulator KDM4C, which is inducible under hypoxia, 39 and PCGF2, which regulates the hypoxic repsonse. 40 Both factors are known to be expressed by HRS cells. 41, 42 KDM4C was significantly upregulated in PB B cells and the two GCB-DLBCL lines under hypoxic conditions, at least at certain time points of analysis ( Fig. 4C and D Bergisch-Gladbach, Germany) to a purity of >98%.
Hypoxic cell culture
Twentyfour hours prior exposure to hypoxia (1% O 2 ), DLBCL and HL cell lines underwent a standard cell expansion procedure to maintain a uniform cell density and growth rate.
Primary B cells were incubated in culture medium to rest for at least 3 h after isolation. Equal cell amounts were distributed to cell culture plates using the same culture medium. . After incubation at 37°C for 90 min, the absorbance of the solutions was determined at 490 nm using a 96-well plate reader (SAFIRE, Tecan, Austria).
Western blot
Protein extract preparation and Western immunoblotting were performed as described. 28 The lysis buffer contained IGEPAL instead of NP-40 and the primary antibody against HIF-1α (BD Transduction Laboratories, San Jose, USA) was diluted 1:1 000. Additionally, we detected JUN by using the c-Jun antibody clone sc-74543 (Santa Cruz, Dallas, USA; 1:2 000), and β-actin (Sigma-Aldrich, St. Louis, USA; 1:2 000) as a loading control. As secondary antibodies peroxidase-conjugated anti-mouse or anti-rabbit IgG antibodies (Sigma-Aldrich) were used at a 1:10 000 dilution. Immunoreactive proteins were visualized using the Luminol Coumaric acid H 2 O 2 system followed by digital detection (Fusion FX7, Peqlab, Erlangen, Germany).
Flow cytometry and survival assay
To analyse the expression of B cell surface markers, their mean fluorescence intensity (MFI) was determined by flow cytometry using a FACS-Canto cytometer (Becton Dickinson, Heidelberg, Germany). Cells were stained with anti-CD19-PE (BD Biosciences, Becton Dickinson) and anti-CD79b-FITC (SN8, DakoCytomation, Hamburg, Germany) antibodies.
Cell survival was analysed using the BD Biosciences Annexin V Apoptosis Detection KIT and propidium iodide (PI) (Invitrogen, Carlsbad, USA). For combined analyses only annexin V-APC negative (living) cells were gated to determine the MFI of anti-CD19-PE and antiCD79b-FITC staining.
RNA isolation, cDNA synthesis and real-time reverse transcription (RT)-PCR
Cells were lysed and disrupted with Qiashredder™ (Qiagen, Hilden, Germany). Total RNA was prepared from 0.5-1x 10 6 cells using the peqGOLD MicroSpin Total RNA Kit (Peqlab).
Ten µL of total RNA were reverse transcribed using the High capacity cDNA reverse transcription kit (Applied Biosystems). Quantitative real-time RT (qRT)-PCR analysis was performed on an ABI Prism 7900HT Fast Real-Time PCR System (Applied Biosystems) using predesigned Taqman assays (Applied Biosystems) or specific primers and the SYBR Green PCR Master Mix (Sigma) (Suppl. Table 1 ).
